PPBT
Purple Biotech
PPBT
PPBT
5 hedge funds and large institutions have $96K invested in Purple Biotech in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
$53K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
$8K |
| 3 |
VF
Virtu Financial
New York
|
$16K |
| 4 |
UBS Group
Zurich,
Switzerland
|
$6K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $53K | +$31.1K | +200 | +142% |
|
|
VF
2
Virtu Financial
New York
| $16K | +$6.75K | +43 | +73% |
|
|
KWM
3
Kingsview Wealth Management
Grants Pass,
Oregon
| $13K | – | – | – |
|
|
ASN
4
Advisory Services Network
Atlanta,
Georgia
| $8K | +$6.92K | +45 | +643% |
|
|
5
UBS Group
Zurich,
Switzerland
| $6K | +$5.17K | +31 | +620% |
|